Sharawat Indar K, Suthar Renu, Sankhyan Naveen, Singhi Pratibha
Pediatric Neurology Division, Department of Pediatrics, All India Institute of Medical Sciences, Rishikesh, India.
Pediatric Neurology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
J Pediatr Neurosci. 2020 Apr-Jun;15(2):132-134. doi: 10.4103/jpn.JPN_101_19. Epub 2020 Jun 27.
Hypokalemic periodic paralysis (HPP) is a rare genetically determined neuromuscular disorder caused by mutation in skeletal muscles calcium and sodium channels. It presents with recurrent episodes of flaccid paralysis. A 9-year-old girl presented with recurrent episodic flaccid quadriparesis with complete recovery in-between the episodes. Investigations during the acute episode revealed marked hypokalemia with electrocardiogram changes. Next-generation sequencing showed pathogenic missense mutation in gene. She responded well to oral potassium supplementation, acetazolamide, and spironolactone therapy. Muscle weakness in HPP is reversible, and long-term management reduces frequency of paralysis and prevents permanent weakness.
低钾性周期性麻痹(HPP)是一种罕见的由骨骼肌钙通道和钠通道突变引起的遗传性神经肌肉疾病。其表现为反复发作的弛缓性麻痹。一名9岁女孩出现反复发作的弛缓性四肢瘫,发作间期完全恢复。急性发作期检查发现明显低钾血症及心电图改变。二代测序显示某基因存在致病性错义突变。她对口服补钾、乙酰唑胺和螺内酯治疗反应良好。HPP所致的肌无力是可逆的,长期管理可减少麻痹发作频率并预防永久性肌无力。